Pharmosa Biopharm Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	743.83	974.06	672.51	461.46	414.54
Cash & Short-Term Investments	1,613	974.06	672.51	461.46	414.54
Cash Growth	42.18%	44.84%	45.74%	11.32%	-
Other Receivables	6.33	1.47	0.29	0.31	0.15
Receivables	18.68	1.47	0.29	0.31	0.15
Inventory	18.95	21.91	-	-	-
Prepaid Expenses	24.23	12.67	11.65	14.18	8.69
Other Current Assets	-	-	-	0.02	4
Total Current Assets	1,675	1,010	684.45	475.96	427.37
Property, Plant & Equipment	231.25	180.61	30.12	33.44	40.86
Long-Term Investments	73.33	71.22	65.69	61.6	60.91
Other Intangible Assets	0.39	0.09	0.15	0.18	-
Other Long-Term Assets	99.02	71.62	18.95	15.19	14.13
Total Assets	2,079	1,334	799.37	586.37	543.27
Accounts Payable	0.19	0.59	-	-	-
Accrued Expenses	-	33.24	12.28	11.66	10.43
Short-Term Debt	-	-	-	-	61
Current Portion of Long-Term Debt	-	1.26	3.52	8.43	18.81
Current Portion of Leases	17.83	24.69	7.19	6.8	6.43
Other Current Liabilities	41.54	17.8	4.77	6.19	2.58
Total Current Liabilities	66.45	77.58	27.77	33.07	99.25
Long-Term Debt	-	1.19	2.45	5.96	14.83
Long-Term Leases	104.17	117.23	8.04	15.9	23.36
Total Liabilities	175.67	195.99	38.25	54.93	137.44
Common Stock	645.09	586.02	554.67	489.24	402.5
Additional Paid-In Capital	-	531.34	1,180	-	454.19
Retained Earnings	-181.3	20.28	-973.44	-706.94	-450.46
Comprehensive Income & Other	1,439	0.01	0.01	749.13	-0.41
Shareholders' Equity	1,903	1,138	761.12	531.44	405.83
Total Liabilities & Equity	2,079	1,334	799.37	586.37	543.27
Total Debt	122	144.37	21.19	37.09	124.43
Net Cash (Debt)	1,491	829.69	651.32	424.37	290.1
Net Cash Growth	51.51%	27.39%	53.48%	46.28%	-
Net Cash Per Share	12.06	7.32	6.61	5.00	6.09
Filing Date Shares Outstanding	128.65	117.2	110.93	97.85	49.99
Total Common Shares Outstanding	128.65	117.2	110.93	97.85	49.99
Working Capital	1,608	932.53	656.68	442.89	328.12
Book Value Per Share	14.79	9.71	6.86	5.43	8.12
Tangible Book Value	1,903	1,138	760.97	531.25	405.83
Tangible Book Value Per Share	14.79	9.71	6.86	5.43	8.12
Machinery	-	27.11	26.37	17.05	19.59
Construction In Progress	-	35.61	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.